Generic Name |
Imatinib + Dovitinib | |
---|---|---|
IND |
||
Brand Name (US) |
Gleevec + Dovitinib | |
Manufacturer |
Novartis | |
Drug Type |
||
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
KIT Protein + GIST cell based | |
Strategy |
Block KIT + Block blood vessel growth | |
Drug Category |
KIT/PDGFRA inhibitor+ VEGF inhibitor (TKI) |
Links |
|
Trials of this drug |
|
|
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors |
Trial results |